RxDoctor Payments Data

Ujjwal Datta, DPM

Foot Surgery · Perth Amboy, NJNPI 1760486385

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.1% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 9 manufacturers reported payments, led by Ortho Dermatologics, A Division Of Bausch Health US, LLC at 51.5% of the total. Reporting peaked in 2023 at $178 and has fallen 65.7% since, to $61 in 2025. That places this record below the midpoint for foot surgery clinicians in NJ, where the typical reported total is $943.

$289in general payments, 2019–2025

Across 9 payments — averaging $32.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Ortho Dermatologics, A Division Of Bausch Health US, LLC$149
  • Exact Sciences$26
  • Mckesson Medical-surgical, Inc.$20
  • Lilly USA, LLC$19
  • Bioventus LLC$18
  • Advanced Oxygen Therapy Inc.$16
  • plus $42 from 3 others

What the payments were for

  • Speaking & faculty fees$207%
  • Food & beverage$26993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$289 in reported general payments places this provider in the 30th percentile of 59 foot surgery providers in New Jersey.

See all foot surgery providers in New Jersey

Medicare billing

Part B allowed, 2024
$11,590
Medicare patients
48
Services billed
135

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate184$5,095
Ciclopirox57$2,268
Diclofenac Sodium44$882
Ketoconazole49$821
Amitriptyline Hcl52$702
Pregabalin30$507
Terbinafine Hcl22$247
Meloxicam46$153

Paid to pharmacies, not to this prescriber.

Other foot surgery in Perth Amboy

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →